Radiological Diagnosis of Soft Tissue Tumors in Adults: MRI Imaging of Selected Entities Delineating Benign and Malignant Tumors

Catharina Silvia Lisson; Christoph Gerhard Lisson; Meinrad Beer; Stefan Andreas Schmidt

doi:10.1055/a-0715-2205

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, Inhaltsverzeichnis

Rofo 2019; 191(04): 323-332
DOI: 10.1055/a-0715-2205

Review

Radiological Diagnosis of Soft Tissue Tumors in Adults: MRI Imaging of Selected Entities Delineating Benign and Malignant Tumors

Artikel in mehreren Sprachen: English | deutsch

Autor*innen

Catharina Silvia Lisson

Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
Christoph Gerhard Lisson

Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
Meinrad Beer

Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany
Stefan Andreas Schmidt

Department of Diagnostic and Interventional Radiology, University-Hospital of Ulm, Germany

Abstract

Objective MRI is the most important and sensitive imaging modality in the differentiation of unclear soft tissue tumors. A systematic approach helps to narrow down the large number of possible differential diagnoses.

Method Our review systematically compares MRI characteristics of the major soft-tissue masses and aims to gain access to these often difficult tumor entities.

Results and conclusion MRI, as the most important modality in the imaging of soft tissue tumors, allows a more detailed classification of the tumor entity and in many cases a differentiation between benign and malignant masses.

Key points:

MRI is the method of choice for classifying unclear soft tissue tumors.
A systematic approach may differentiate benign from unclear lesions.
In cases of doubt, a biopsy should be performed to rule out malignancy.

Citation Format

Lisson CS, Lisson CG, Beer M et al. Radiological Diagnosis of Soft Tissue Tumors in Adults: MRI Imaging of Selected Entities Delineating Benign and Malignant Tumors. Fortschr Röntgenstr 2019; 191: 323 – 332

Key words

muscular - skeletal-appendicular - skeletal-axial - soft tissues - neoplasms

Volltext

Referenzen

Literatur
1 Breitenseher M. Bildgebende Diagnostik und Therapie der Weichteiltumoren: mit pathologischer Klassifikation, Nuklearmedizin, interventioneller Therapie; 21 Tabellen. Thieme; 2008
2 Bannasch H, Eisenhardt SU, Grosu AL. et al. The diagnosis and treatment of soft tissue sarcomas of the limbs. Deutsches Arzteblatt international 2011; 108: 32-38
3 Murphey MD, Carroll JF, Flemming DJ. et al. From the archives of the AFIP: benign musculoskeletal lipomatous lesions. Radiographics 2004; 24: 1433-1466
4 Kransdorf MJ, Bancroft LW, Peterson JJ. et al. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology 2002; 224: 99-104
5 Bancroft LW, Kransdorf MJ, Peterson JJ. et al. Benign fatty tumors: classification, clinical course, imaging appearance, and treatment. Skeletal radiology 2006; 35: 719-733
6 Goldblum JR, Weiss SW, Folpe AL. Enzinger and Weiss's Soft Tissue Tumors E-Book. Elsevier Health Sciences; 2013
7 Jelinek JS, Kransdorf MJ, Shmookler BM. et al. Liposarcoma of the extremities: MR and CT findings in the histologic subtypes. Radiology 1993; 186: 455-459
8 Zhang H, Erickson-Johnson M, Wang X. et al. Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors. Am J Surg Pathol 2010; 34: 1304-1311
9 Wang XL, De Schepper AM, Vanhoenacker F. et al. Nodular fasciitis: correlation of MRI findings and histopathology. Skeletal radiology 2002; 31: 155-161
10 Fletcher CDM, Unni KK, Mertens F. et al. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press; 2002
11 Crundwell N, O'Donnell P, Saifuddin A. Non-neoplastic conditions presenting as soft-tissue tumours. Clinical radiology 2007; 62: 18-27
12 Parikh J, Hyare H, Saifuddin A. The imaging features of post-traumatic myositis ossificans, with emphasis on MRI. Clinical radiology 2002; 57: 1058-1066
13 Kransdorf MJ, Meis JM. From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremities. Radiographics 1993; 13: 853-884
14 Jackson DW. Managing Myositis Ossificans in the Young Athlete. Physician and Sportsmedicine 1975; 3: 56-61
15 Berlien H, Poetke M, Philipp C. et al. Phakomatosen. In: Oldhafer M. Hrsg Transitionsmedizin. Stuttgart: Schattauer; 2015: 169-180
16 International Society for the Study of Vascular Anomalies. ISSVA classification for vascular anomalies (Approved at the 20th ISSVA Workshop, Melbourne, April 2014, last revision May 2018). Available via http://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf . Accessed 7 Jul 2018
17 Berlien H, Urban P, Poetke M. et al. Klassifikation der Vaskulären Malformationen. Phlebologie 2016; 45: 295-303
18 Kransdorf MJ, Murphey MD. Imaging of Soft Tissue Tumors. Lippincott Williams & Wilkins; 2006
19 Vilanova JC, Barcelo J, Smirniotopoulos JG. et al. Hemangioma from head to toe: MR imaging with pathologic correlation. Radiographics 2004; 24: 367-385
20 Murphey MD, Fairbairn KJ, Parman LM. et al. From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics 1995; 15: 893-917
21 Papp DF, Khanna AJ, McCarthy EF. et al. Magnetic resonance imaging of soft-tissue tumors: determinate and indeterminate lesions. The Journal of bone and joint surgery American volume 2007; 89 (Suppl. 03) 103-115
22 Myers BW, Masi AT. Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine (Baltimore) 1980; 59: 223-238
23 Dorwart RH, Genant HK, Johnston WH. et al. Pigmented villonodular synovitis of synovial joints: clinical, pathologic, and radiologic features. Am J Roentgenol 1984; 143: 877-885
24 Al-Nakshabandi NA, Ryan AG, Choudur H. et al. Pigmented villonodular synovitis. Clinical radiology 2004; 59: 414-420
25 Cotten A, Flipo RM, Chastanet P. et al. Pigmented villonodular synovitis of the hip: review of radiographic features in 58 patients. Skeletal radiology 1995; 24: 1-6
26 Llauger J, Palmer J, Roson N. et al. Pigmented villonodular synovitis and giant cell tumors of the tendon sheath: radiologic and pathologic features. Am J Roentgenol 1999; 172: 1087-1091
27 Karasick D, Karasick S. Giant cell tumor of tendon sheath: spectrum of radiologic findings. Skeletal radiology 1992; 21: 219-224
28 De Beuckeleer L, De Schepper A, De Belder F. et al. Magnetic resonance imaging of localized giant cell tumour of the tendon sheath (MRI of localized GCTTS). Eur Radiol 1997; 7: 198-201
29 Murphey MD, Rhee JH, Lewis RB. et al. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics 2008; 28: 1493-1518
30 Kransdorf MJ. Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location. Am J Roentgenol 1995; 164: 395-402
31 Banks KP. The target sign: extremity. Radiology 2005; 234: 899-900
32 Murphey MD, Smith WS, Smith SE. et al. From the archives of the AFIP. Imaging of musculoskeletal neurogenic tumors: radiologic-pathologic correlation. Radiographics 1999; 19: 1253-1280
33 Kalayanarooj S. Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination. J Med Assoc Thai 2008; 91: 74-81
34 Enochs WS, Hyslop WB, Bennett HF. et al. Sources of the increased longitudinal relaxation rates observed in melanotic melanoma. An in vitro study of synthetic melanins. Invest Radiol 1989; 24: 794-804
35 White LM, Schweitzer ME, Khalili K. et al. MR imaging of primary lymphoma of bone: variability of T2-weighted signal intensity. Am J Roentgenol 1998; 170: 1243-1247
36 Sundaram M, McGuire MH, Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. Am J Roentgenol 1987; 148: 1247-1250
37 Dinauer PA, Brixey CJ, Moncur JT. et al. Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics 2007; 27: 173-187
38 Martinez S, Vogler 3rd JB, Harrelson JM. et al. Imaging of tumoral calcinosis: new observations. Radiology 1990; 174: 215-222
39 Harish S, Lee JC, Ahmad M. et al. Soft tissue masses with “cyst-like” appearance on MR imaging: Distinction of benign and malignant lesions. Eur Radiol 2006; 16: 2652-2660
40 Stiskal MA, Neuhold A, Szolar DH. et al. Rheumatoid arthritis of the craniocervical region by MR imaging: detection and characterization. Am J Roentgenol 1995; 165: 585-592
41 Kransdorf MJ, Murphey MD. Radiologic evaluation of soft-tissue masses: a current perspective. Am J Roentgenol 2000; 175: 575-587
42 Ma LD, McCarthy EF, Bluemke DA. et al. Differentiation of benign from malignant musculoskeletal lesions using MR imaging: pitfalls in MR evaluation of lesions with a cystic appearance. Am J Roentgenol 1998; 170: 1251-1258
43 Frassica FJ, Khanna JA, McCarthy EF. The role of MR imaging in soft tissue tumor evaluation: perspective of the orthopedic oncologist and musculoskeletal pathologist. Magn Reson Imaging Clin N Am 2000; 8: 915-927
44 Ma LD, Frassica FJ, Scott Jr WW. et al. Differentiation of benign and malignant musculoskeletal tumors: potential pitfalls with MR imaging. Radiographics 1995; 15: 349-366
45 Sundaram M, Sharafuddin MJ. MR imaging of benign soft-tissue masses. Magn Reson Imaging Clin N Am 1995; 3: 609-627
46 Jelinek J, Kransdorf MJ. MR imaging of soft-tissue masses. Mass-like lesions that simulate neoplasms. Magnetic Resonance Imaging Clinics of North America 1995; 3: 727-741
47 Beggs I. Pictorial review: imaging of peripheral nerve tumours. Clinical radiology 1997; 52: 8-17
48 Blacksin MF, Siegel JR, Benevenia J. et al. Synovial sarcoma: frequency of nonaggressive MR characteristics. J Comput Assist Tomogr 1997; 21: 785-789
49 Tateishi U, Hasegawa T, Beppu Y. et al. Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma. Am J Roentgenol 2004; 182: 725-731
50 Misra A, Mistry N, Grimer R. et al. The management of soft tissue sarcoma. J Plast Reconstr Aesthet Surg 2009; 62: 161-174
51 Verstraete KL, De Deene Y, Roels H. et al. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994; 192: 835-843
52 van der Woude HJ, Verstraete KL, Hogendoorn PC. et al. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?. Radiology 1998; 208: 821-828
53 Kettelhack C, Wickede M, Vogl T. et al. 31Phosphorus-magnetic resonance spectroscopy to assess histologic tumor response noninvasively after isolated limb perfusion for soft tissue tumors. Cancer 2002; 94: 1557-1564
54 Einarsdottir H, Karlsson M, Wejde J. et al. Diffusion-weighted MRI of soft tissue tumours. Eur Radiol 2004; 14: 959-963
55 Dudeck O, Zeile M, Pink D. et al. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 2008; 27: 1109-1113
56 Burrell RA, McGranahan N, Bartek J. et al. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 2013; 501: 338-345
57 Lisson CS, Lisson CG, Flosdorf K. et al. Diagnostic value of MRI-based 3D texture analysis for tissue characterisation and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study. Eur Radiol 2018; 28: 468-477